Save time and get answers to complex questions with AI chat
Drugpatentwatch market analysis industry today?Albendazole side effects in humans?Xiaflex market launch year?Allergan's patent for latisse expired?The expiration date of the key patent for guselkumab?
See the DrugPatentWatch profile for Keppra
Keppra (levetiracetam) is approved for seizures, but doctors sometimes use it for other conditions “off label.” Here’s a quick overview of common off-label areas and what the evidence says: Common off-label uses (with caveats) - Status epilepticus and refractory seizures in hospital: IV levetiracetam is widely used as a second-line option. This is one of the more common off-label uses and is supported by clinical experience and some guidelines, though it isn’t a formal FDA indication for status epilepticus. - Mood disorders (e.g., bipolar disorder) and agitation: some small studies and case reports suggest possible mood stabilization or reduction in aggression in some people, but the evidence is limited and not robust. Not a standard, first-line treatment. - Autism spectrum disorder (behavioral issues like irritability/aggression): limited and mixed evidence from small studies; not established. - Neuropathic pain or migraines: very limited data; not considered a proven or standard use. - Other rare/unsupported uses: there are scattered case reports, but nothing strong enough to broadly recommend. What to consider - Evidence varies by use; most off-label uses have only small or inconclusive studies. - Safety: Keppra is generally well tolerated, but can cause mood or behavior changes (irritability, agitation, aggression, anxiety), sleepiness, dizziness. In rare cases, psychiatric symptoms or suicidality can occur. Always monitor for new or worsening symptoms and discuss with a clinician. - Dosing and kidney function: dosing for off-label uses isn’t standardized and often depends on kidney function, age, and concomitant meds. Do not adjust or stop doses without medical advice. - Pregnancy and lactation: levetiracetam is often chosen because it’s relatively clean pharmacologically, but decisions about use in pregnancy should be made with a clinician. If you have a specific off-label use in mind (e.g., for a particular condition, or you’re considering stopping/adjusting Keppra), tell me the condition and your situation and I can share more targeted information and what to discuss with your doctor.
Other Questions About Keppra :